Study of a new medicine TESP-0401 in healthy people
This study tests a new medicine called TESP-0401 in healthy people to see if it is safe and how the body handles it. It is an early-stage trial, and you will stay at a clinic for part of the study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be generally healthy, with no significant heart, lung, liver, kidney, or mental health problems.
- Your blood pressure and heart rate need to be within a certain range (e.g., blood pressure at least 100 mmHg, resting heart rate at least 50 beats per minute).
- Your body mass index (BMI) must be between 18 and 32.
- You must not have taken any prescription or over-the-counter medications (including herbal supplements) in the past 30 days.
- You must be willing to avoid smoking or nicotine products for 7 days before the study and throughout the study.
- You must agree to stay at the study clinic for the required period.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage safety study testing a new experimental drug called ZE74-0282 in healthy volunteers. Researchers want to learn how safe the drug is and how well people tolerate it before testing it in patients with a disease.
This trial tests different doses of a new study drug in healthy people to see how safe it is and how the body handles it. Participation involves taking the drug and having regular check-ups.
This study tests a new medicine in healthy people to see if it is safe and how the body handles it. Participating could help understand side effects before testing in patients.
This study tests a new medicine called NNC0705-0002 in healthy volunteers to see if it is safe and how the body handles it. It helps find the right dose for future studies.
This trial tests a new medicine called RO7806881 in healthy volunteers to see if it is safe, what dose is best, and how the body handles it. It is an early study that helps researchers decide if the drug should be tested in people with a disease.
This study tests a single dose of a new tablet medication (called TRTL-729) in healthy adults. It helps researchers learn how the drug is absorbed and tolerated, which is a first step in developing a treatment.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.